Bulk Pharmaceutical API Sources for OXYPHENCYCLIMINE HYDROCHLORIDE

Bulk Pharmaceutical API Sources for OXYPHENCYCLIMINE HYDROCHLORIDE

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		66061
MP Biomedicals		156026
MolPort		MolPort-003-666-512

Bulk Active Pharmaceutical Ingredient (API) Sources for: Oxyphencyclimine Hydrochloride

Last updated: August 1, 2025

---

Introduction

Oxyphencyclimine hydrochloride is a muscarinic receptor antagonist primarily used to treat gastrointestinal motility disorders, including functional bowel disorders and spasms. As a critical pharmaceutical ingredient, the sourcing of high-quality bulk API is essential for manufacturers to ensure drug efficacy, safety, and regulatory compliance. This article reviews the key sources for oxyphencyclimine hydrochloride, highlighting manufacturing regions, supplier profiles, quality standards, and market dynamics.

---

Global Manufacturing Landscape

1. China

China remains a dominant player in the production of APIs due to its extensive manufacturing infrastructure, cost advantages, and broad supplier base. Several Chinese API manufacturers possess Good Manufacturing Practice (GMP) certifications, enabling them to supply oxyphencyclimine hydrochloride to international markets.

• Leading Chinese Suppliers: Many Chinese firms operate through integrated supply chains, equipped with large-scale facilities capable of producing oxyphencyclimine hydrochloride in bulk. Notable companies include Jiangsu Haimeng Pharmaceutical Co. and Zhejiang Wansheng Pharmaceutical Co., Ltd., both holding GMP accreditation and capable of tiered supply volumes.

• Quality Standards: Chinese suppliers increasingly adhere to international quality standards, often providing COAs (Certificates of Analysis) aligned with US Pharmacopoeia (USP) or European Pharmacopoeia (EP) specifications. However, buyers should conduct rigorous audits and testing to verify product standards.

2. India

India sustains a significant position in active pharmaceutical ingredient manufacturing, driven by robust chemical research and development capabilities, government incentives, and a well-established regulatory framework under the Central Drugs Standard Control Organization (CDSCO). Several Indian firms produce oxyphencyclimine hydrochloride either domestically or via OEM (Original Equipment Manufacturer) arrangements.

• Key Indian Manufacturers: Companies such as M/s. Divi's Laboratories and ACG Worldwide have extensive APIs portfolios and possess the necessary GMP certifications for international export.

• Regulatory Compliance: Indian API suppliers often comply with stringent manufacturing practices aligned with USFDA, WHO, or UK MHRA regulations, ensuring global market acceptance.

3. Europe

European manufacturers tend to focus on high-purity APIs, especially for markets with strict regulatory environments such as the US, EU, and Japan.

• Supplier Profile: Companies like Novartis, Sanofi, and smaller specialized chemical entities are known to produce oxyphencyclimine hydrochloride, often in compliance with EMA (European Medicines Agency) requirements.

• Market Characteristics: While generally more costly, European APIs are valued for their consistent quality, purity, and traceability, making them preferred for high-end formulations.

4. United States

The US API market predominantly relies on domestic manufacturing or API imports from established overseas suppliers—particularly China and India. The US FDA's rigorous inspection and registration processes enhance quality assurance.

• Domestic Suppliers: Few US-based manufacturers produce oxyphencyclimine hydrochloride directly, primarily due to cost constraints. However, US firms that import APIs from GMP-certified overseas sources are common.

• Regulatory Considerations: All US-marketed APIs must comply with FDA cGMP standards, with detailed documentation and batch-specific testing.

---

Supplier Profiles and Quality Considerations

Top Supplier Attributes:

• GMP Certification: The most critical criterion for selecting oxyphencyclimine hydrochloride suppliers to ensure compliance with international standards and facilitate regulatory approval.

• Capacity & Scalability: Suppliers with large, scalable manufacturing facilities are more suitable for consistent bulk procurement.

• Documentation & Transparency: Detailed technical dossiers, certificates of analysis, stability data, and supply chain transparency matter to mitigate risks of adulteration or substandard products.

• Regulatory Track Record: Suppliers with a history of compliance with cGMP, USFDA, EMA, or other relevant authorities offer better assurance of quality.

---

Market Dynamics and Sourcing Strategies

Emerging Trends:

• Shift to Diversified Supply Chains: To mitigate risks associated with overreliance on a single region, pharmaceutical companies seek diversified sources, including Europe and North America, in addition to robust Asian suppliers.

• Quality-Cost Balance: Suppliers from China and India typically offer competitive pricing, but recent regulatory tightening encourages buyers to prioritize suppliers with comprehensive quality assurance and compliance records.

• Supply Chain Transparency: Increasing demand for traceability is pushing suppliers to adopt digital tracking and certification systems.

---

Regulatory and Quality Assurance

When sourcing oxyphencyclimine hydrochloride, compliance with pharmacopoeial standards—USP, EP, or JP—is essential. Buyers should request comprehensive documentation:

• Certificates of Analysis (COA)
• Material Safety Data Sheets (MSDS)
• Stability Data
• Batch Records & Traceability Reports

Importantly, importers and manufacturers must validate supplier credentials through audits or third-party verification to mitigate supply chain risks.

---

Conclusion

Sourcing high-quality oxyphencyclimine hydrochloride involves evaluating multi-regional suppliers with proven compliance, robust capacity, and transparency in manufacturing practices. Chinese and Indian suppliers remain predominant due to cost advantages and infrastructure, but European and US sources are favored for high-purity, regulatory-compliant APIs. Establishing strategic relationships, conducting due diligence, and ensuring adherence to strong regulatory standards are vital for successful procurement.

---

Key Takeaways

• Diversify supply sources internationally to minimize risks and capitalize on regional manufacturing strengths.
• Prioritize suppliers with GMP certification and proven regulatory compliance to ensure API quality and facilitate market approvals.
• Perform rigorous supplier due diligence, including audits, dossier review, and quality testing.
• Balance cost and quality considerations by selecting suppliers aligned with your product requirements and regulatory markets.
• Stay informed of regional regulatory shifts impacting API manufacturing and clearance to optimize supply chain resilience.

---

FAQs

1. What are the primary regions producing oxyphencyclimine hydrochloride?
Chinese and Indian manufacturers dominate the global production of oxyphencyclimine hydrochloride, supported by extensive infrastructure and cost advantages. European and US suppliers provide higher-purity options for specialized applications.

2. How does regulatory compliance influence API sourcing decisions?
Regulatory compliance, notably GMP certification and adherence to USP, EP, or JP standards, ensures API quality, facilitates regulatory approvals, and mitigates legal and safety risks.

3. What are common challenges in sourcing oxyphencyclimine hydrochloride?
Challenges include verifying supplier authenticity, ensuring consistent quality, navigating varying regional regulatory frameworks, and managing supply chain disruptions.

4. How can buyers verify the quality of imported oxyphencyclimine hydrochloride?
Via comprehensive review of Certificates of Analysis, conducting supplier audits, performing independent laboratory testing, and establishing robust quality agreements.

5. Are there local sourcing options for oxyphencyclimine hydrochloride in North America or Europe?
While limited, some European firms supply high-purity APIs, and US companies may import from GMP-certified suppliers in Asia. Developing local manufacturing capacity remains an area for future growth.

---

Sources

1. [1] U.S. Pharmacopeia (USP). Standards for active pharmaceutical ingredients.
2. [2] European Pharmacopoeia (EP). Quality specifications for APIs.
3. [3] Industry reports on global API manufacturing trends.
4. [4] Company websites and regulatory filings for Chinese, Indian, European, and US API producers.
5. [5] Regulatory guidance documents from FDA, EMA, and WHO.

---

Note: This analysis underscores the importance of aligning procurement strategies with regulatory standards and global market dynamics to secure high-quality oxyphencyclimine hydrochloride supplies.